Autor: "Kendall DM" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus.
Autorzy :: McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri, USA.
Weiss D; Your Diabetes Endocrine Nutrition Group, Inc, Mentor, Ohio, USA.
Grant M; MannKind Corporation, Westlake Village, California, USA.
Jones MC; MannKind Corporation, Westlake Village, California, USA.
Kendall DM; MannKind Corporation, Westlake Village, California, USA.
Hoogwerf BJ; Endocrinology, Diabetes and Metabolism (Emeritus), Cleveland Clinic, Cleveland, Ohio, USA.; Pokaż więcej
Źródło :: Journal of diabetes [J Diabetes] 2021 Feb; Vol. 13 (2), pp. 164-172. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Blood Glucose/*analysis
Diabetes Mellitus, Type 1/*drug therapy
Glycated Hemoglobin A/*analysis
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Administration, Inhalation ; Adult ; Diabetes Mellitus, Type 1/blood ; Female ; Humans ; Hypoglycemic Agents/administration & dosage ; Insulin/administration & dosage ; Male ; Middle Aged ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
Autorzy :: Hoogwerf BJ; Department of Endocrinology, Diabetes, and Metabolism (Emeritus), Cleveland, Ohio.
Pantalone KM; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio.
Basina M; Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California.
Jones MC; MannKind Corporation, Westlake Village, California. Electronic address: .
Grant M; MannKind Corporation, Westlake Village, California.
Kendall DM; MannKind Corporation, Westlake Village, California.; Pokaż więcej
Źródło :: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2021 Jan; Vol. 27 (1), pp. 38-43. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Diabetes Mellitus, Type 2*/drug therapy
Insulin Aspart*
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Blood Glucose ; Glycated Hemoglobin A/analysis ; Humans ; Hypoglycemic Agents ; Insulin ; Insulin Glargine ; Insulin, Long-Acting ; Male ; Middle Aged ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Comprehensive Pulmonary Safety Review of Inhaled Technosphere Insulin in Patients with Diabetes Mellitus.
Autorzy :: McGill JB; Washington University School of Medicine, St Louis, MO, USA.
Peters A; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Buse JB; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Steiner S; MannKind Corporation, Westlake Village, CA, USA.
Tran T; MannKind Corporation, Westlake Village, CA, USA.
Pompilio FM; MannKind Corporation, Westlake Village, CA, USA.; Arcutis Biotherapeutics, Inc, Westlake Village, CA, USA.
Kendall DM; MannKind Corporation, Westlake Village, CA, USA. .; Pokaż więcej
Źródło :: Clinical drug investigation [Clin Drug Investig] 2020 Oct; Vol. 40 (10), pp. 973-983.
Typ publikacji :: Journal Article
MeSH Terms :: Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosage
Lung/*drug effects
Administration, Inhalation ; Adult ; Blood Glucose/metabolism ; Cough/drug therapy ; Female ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin/adverse effects ; Male ; Middle Aged ; Postprandial Period ; Powders/therapeutic use ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Hypoglycaemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus.
Autorzy :: Seaquist ER; University of Minnesota, Minneapolis, MN, USA.
Blonde L; Ochsner Medical Center, New Orleans, LA, USA.
McGill JB; Washington University School of Medicine, St Louis, MO, USA.
Heller SR; University of Sheffield, Sheffield, UK.
Kendall DM; MannKind Corporation, Westlake Village, CA, USA.
Bumpass JB; MannKind Corporation, Westlake Village, CA, USA.
Pompilio FM; MannKind Corporation, Westlake Village, CA, USA.
Grant ML; MannKind Corporation, Westlake Village, CA, USA.; Pokaż więcej
Źródło :: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2020 May; Vol. 37 (5), pp. 752-759. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy.
Autorzy :: Ray KK; Faculty of Medicine, School of Public Health, Imperial College, London, UK.
Kendall DM; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Zhao Z; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Peng X; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Caballero AE; Harvard Medical School, Boston, Massachusetts.
Polonsky WH; Behavioral Diabetes Institute, San Diego, California.
Nordstrom BL; Real-world Evidence, Evidera, Waltham, Massachusetts.
Fan L; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Curtis BH; Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana.
Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK.; Pokaż więcej
Źródło :: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 May; Vol. 21 (5), pp. 1101-1110. Date of Electronic Publication: 2019 Jan 24.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Diabetes Mellitus, Type 2/*drug therapy
Diabetes Mellitus, Type 2/*pathology
Insulin/*therapeutic use
Aged ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/economics ; Disease Progression ; Female ; Follow-Up Studies ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility/economics ; Health Services Accessibility/statistics & numerical data ; Humans ; Income ; Insulin/economics ; Male ; Middle Aged ; Self Efficacy ; Socioeconomic Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes.
Autorzy :: Conget I; a Endocrinology and Diabetes Unit , Hospital Clinic I Universitari , Barcelona , Spain.
Kirkman MS; b Division of Endocrinology , University of North Carolina , Chapel Hill , NC , USA.
Cao D; c Eli Lilly and Company , Indianapolis , IN , USA.
Wong M; c Eli Lilly and Company , Indianapolis , IN , USA.
Reviriego J; d Eli Lilly and Company , Madrid , Spain.
Kendall DM; c Eli Lilly and Company , Indianapolis , IN , USA.; Pokaż więcej
Źródło :: Current medical research and opinion [Curr Med Res Opin] 2018 Feb; Vol. 34 (2), pp. 329-336. Date of Electronic Publication: 2017 Nov 24.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Insulin Lispro*/administration & dosage
Insulin Lispro*/adverse effects
Glycated Hemoglobin A/*analysis
Aged ; Biomarkers/analysis ; Databases, Factual/statistics & numerical data ; Drug Monitoring/methods ; Endpoint Determination/methods ; Female ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Male ; Middle Aged ; Outcome Assessment, Health Care/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.
Autorzy :: Lebrec J; Lilly Deutschland GmbH, Bad Homburg, Germany.
Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA.
Chen YF; Eli Lilly and Company, Indianapolis, IN, USA.
Reed C; Eli Lilly and Company Limited, Lilly Research Centre, Windlesham, Surrey, UK. .
Kahle-Wrobleski K; Eli Lilly and Company, Indianapolis, IN, USA.
Hake AM; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Raskin J; Eli Lilly and Company, Toronto, Canada.
Naderali E; Eli Lilly and Company, Lilly House, Basingstoke, Hampshire, UK.; Faculty of Science, Liverpool Hope University, Liverpool, UK.
Schuster D; Eli Lilly and Company, Indianapolis, IN, USA.
Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.; Pokaż więcej
Źródło :: BMC geriatrics [BMC Geriatr] 2016 May 03; Vol. 16, pp. 93. Date of Electronic Publication: 2016 May 03.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Cost of Illness*
Alzheimer Disease/*epidemiology
Alzheimer Disease/*psychology
Caregivers/*psychology
Diabetes Mellitus/*epidemiology
Diabetes Mellitus/*psychology
Activities of Daily Living/psychology ; Adaptation, Psychological ; Aged ; Aged, 80 and over ; Alzheimer Disease/diagnosis ; Cross-Sectional Studies ; Diabetes Mellitus/diagnosis ; Female ; France/epidemiology ; Germany/epidemiology ; Health Resources/statistics & numerical data ; Health Resources/trends ; Humans ; Male ; Prospective Studies ; United Kingdom/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
Autorzy :: Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. .
Cao D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Boye KS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Curtis B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Schuster DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Kendall DM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Ascher-Svanum H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.; Pokaż więcej
Źródło :: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Dec; Vol. 6 (4), pp. 651.
Typ publikacji :: Journal Article; Published Erratum
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
Autorzy :: Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. .
Zagar A; Eli Lilly and Company, Indianapolis, IN, USA.
Jiang D; Eli Lilly and Company, Indianapolis, IN, USA.
Schuster D; Eli Lilly and Company, Indianapolis, IN, USA.
Schmitt H; Eli Lilly Benelux, Brussels, Belgium.
Dennehy EB; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.
Raskin J; Eli Lilly and Company, Indianapolis, IN, USA.
Heine RJ; Eli Lilly Canada, Toronto, ON, Canada.; Pokaż więcej
Źródło :: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Sep; Vol. 6 (3), pp. 303-16. Date of Electronic Publication: 2015 Jul 10.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
Autorzy :: Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. .
Cao D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Boye KS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Curtis B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Schuster DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Kendall DM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Ascher-Svanum H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.; Pokaż więcej
Źródło :: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Sep; Vol. 6 (3), pp. 317-28. Date of Electronic Publication: 2015 Jul 05.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
Autorzy :: Ascher-Svanum H; Eli Lilly and Company, Indianapolis, IN, USA. .
Zagar A; Eli Lilly and Company, Indianapolis, IN, USA.
Jiang D; Eli Lilly and Company, Indianapolis, IN, USA.
Schuster D; Eli Lilly and Company, Indianapolis, IN, USA.
Schmitt H; Eli Lilly Benelux, Brussels, Belgium.
Dennehy EB; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.
Raskin J; Eli Lilly Canada, Toronto, ON, Canada.
Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA.; Pokaż więcej
Źródło :: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2015 Sep; Vol. 6 (3), pp. 403.
Typ publikacji :: Journal Article; Published Erratum
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK.
Autorzy :: Valentine WJ; Ossian Health Economics and Communications, Basel, Switzerland. Electronic address: .
Curtis BH; Eli Lilly and Company, Indianapolis, IN, USA.
Pollock RF; Ossian Health Economics and Communications, Basel, Switzerland.
Van Brunt K; Lilly Research Center, Windlesham, Surrey, UK.
Paczkowski R; Eli Lilly and Company, Indianapolis, IN, USA.
Brändle M; Division of Endocrinology and Diabetes, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Boye KS; Eli Lilly and Company, Indianapolis, IN, USA.
Kendall DM; Eli Lilly and Company, Indianapolis, IN, USA.; Pokaż więcej
Źródło :: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2015 Jul; Vol. 109 (1), pp. 95-103. Date of Electronic Publication: 2015 Apr 21.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Diabetes Mellitus, Type 2/*drug therapy
Diabetes Mellitus, Type 2/*economics
Hypoglycemic Agents/*administration & dosage
Hypoglycemic Agents/*economics
Insulin/*administration & dosage
Insulin/*economics
Standard of Care/*economics
Aged ; Body Mass Index ; Cost-Benefit Analysis ; Costs and Cost Analysis ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Life Expectancy ; Male ; Middle Aged ; Quality of Life ; Retrospective Studies ; United Kingdom/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
Autorzy :: Fu H; 1 Eli Lilly and Company , Indianapolis, Indiana.
Curtis BH
Schuster DP
Festa A
Kendall DM; Pokaż więcej
Źródło :: Diabetes technology & therapeutics [Diabetes Technol Ther] 2014 Dec; Vol. 16 (12), pp. 833-9. Date of Electronic Publication: 2014 Jul 28.
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Aging*
Practice Patterns, Physicians'*
Diabetes Mellitus, Type 2/*drug therapy
Glycated Hemoglobin A/*analysis
Hyperglycemia/*prevention & control
Hypoglycemia/*prevention & control
Hypoglycemic Agents/*therapeutic use
Aged ; Aged, 80 and over ; Cohort Studies ; Diabetes Mellitus, Type 2/blood ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use ; Electronic Health Records ; Female ; Glucagon-Like Peptide-1 Receptor ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemic Agents/adverse effects ; Insulin/adverse effects ; Insulin/therapeutic use ; Male ; Practice Guidelines as Topic ; Receptors, Glucagon/agonists ; Retrospective Studies ; Sulfonylurea Compounds/adverse effects ; Sulfonylurea Compounds/therapeutic use ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Comment on Zhang et Al. Second-line agents for glycemic control for type 2 diabetes: are newer agents better? Diabetes Care 2014;37:1338-1345.
Autorzy :: Bae J; Eli Lilly and Company, Indianapolis, IN.
Curtis BH; Eli Lilly and Company, Indianapolis, IN .
Kendall DM; Eli Lilly and Company, Indianapolis, IN.
Heine RJ; Eli Lilly and Company, Indianapolis, IN.; Pokaż więcej
Źródło :: Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. e204.
Typ publikacji :: Letter; Comment
MeSH Terms :: Diabetes Mellitus, Type 2/*prevention & control
Hypoglycemic Agents/*therapeutic use
Female ; Humans ; Male
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Frederick C. Goetz, MD: a profile of the intersection among science, the fine arts, and education.
Autorzy :: Hoogwerf BJ; Eli Lilly and Co., Indianapolis, IN .
Kendall DM; Eli Lilly and Co., Indianapolis, IN University of Minnesota, Minneapolis, MN.
Seaquist ER; University of Minnesota, Minneapolis, MN.; Pokaż więcej
Źródło :: Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. 2419-23.
Typ publikacji :: Biography; Historical Article; Journal Article
MeSH Terms :: Art*
Education*
Science*
Diabetes Mellitus/*therapy
Kidney Transplantation/*history
Pancreas Transplantation/*history
Health Services ; History, 20th Century ; History, 21st Century ; Humans
Personal Name as Subject :: Goetz FC
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Frequency and causes of hospitalization in older compared to younger adults with type 2 diabetes in the United States: a retrospective, claims-based analysis.
Autorzy :: Fu H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.
Curtis BH; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.
Xie W; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.
Festa A; Eli Lilly and Company, Vienna, Austria.
Schuster DP; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.
Kendall DM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN. Electronic address: .; Pokaż więcej
Źródło :: Journal of diabetes and its complications [J Diabetes Complications] 2014 Jul-Aug; Vol. 28 (4), pp. 477-81. Date of Electronic Publication: 2014 Feb 26.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Aging*
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemia/*chemically induced
Hypoglycemic Agents/*adverse effects
Insulin/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Databases, Factual ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/therapy ; Female ; Health Benefit Plans, Employee ; Hospitalization ; Humans ; Hypoglycemia/prevention & control ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Male ; Middle Aged ; Patient Readmission ; Retrospective Studies ; Survival Analysis ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Comment on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.
Autorzy :: Heine RJ; Lilly Research Laboratories and Lilly Diabetes, Eli Lilly & Co., Indianapolis, Indiana.
Fu H
Kendall DM
Moller DE; Pokaż więcej
Źródło :: Diabetes [Diabetes] 2013 Oct; Vol. 62 (10), pp. e16-7.
Typ publikacji :: Journal Article; Comment
MeSH Terms :: Diabetes Mellitus, Type 2/*drug therapy
Incretins/*therapeutic use
Insulin-Secreting Cells/*drug effects
Pancreas/*drug effects
Female ; Humans ; Male
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Blood pressure targets in diabetes: is this the time for change?
Autorzy :: Kendall DM; American Diabetes Association, Alexandria, VA 22311, USA.; Pokaż więcej
Źródło :: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2011 Apr; Vol. 13 (4), pp. 258-62.
Typ publikacji :: Journal Article
MeSH Terms :: Blood Pressure/*physiology
Diabetes Mellitus/*physiopathology
Hypertension/*physiopathology
Diabetes Mellitus/prevention & control ; Humans ; Hypertension/prevention & control ; Practice Guidelines as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Blood pressure targets in diabetes: is this the time for change?--PRO (Rebuttal).
Autorzy :: Kendall DM; American Diabetes Association, Alexandria, VA 22311, USA.; Pokaż więcej
Źródło :: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2011 Apr; Vol. 13 (4), pp. 266-7.
Typ publikacji :: Comment; Journal Article
MeSH Terms :: Blood Pressure/*physiology
Diabetes Mellitus/*physiopathology
Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Hemoglobin A1c to diagnose diabetes: why the controversy over adding a new tool?
Autorzy :: Kirkman MS; American Diabetes Association, Alexandria, VA 22311, USA. />Kendall DM; Pokaż więcej
Źródło :: Clinical chemistry [Clin Chem] 2011 Feb; Vol. 57 (2), pp. 255-7. Date of Electronic Publication: 2010 Sep 15.
Typ publikacji :: Journal Article
MeSH Terms :: Diabetes Mellitus/*diagnosis
Glycated Hemoglobin A/*analysis
Blood Glucose/analysis ; Diabetes Mellitus/prevention & control ; Hemoglobinometry/methods ; Hemoglobinometry/standards ; Humans ; Practice Guidelines as Topic
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kendall DM"" wg kryterium: Autor

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język